Type
Internal restructuring
Country
Belgium
Region
Vlaams Gewest; Prov. Vlaams Brabant; Arr. Halle-Vilvoorde
Location of affected unit(s)
Diegem
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

87 jobs
Number of planned job losses
Job loss
Announcement Date
1 February 2011
Employment effect (start)
1 February 2011
Foreseen end date
31 December 2012

Description

The French pharmaceutical group Sanofi Aventis has announced, during a works council, the intention to cut 87 jobs at the plant in Diegem as a part of a major restructuring operation affecting also other plants outside Belgium (i.e. Luxembourg). The job losses are blamed on the need to rationalise operations. Closer collaboration between the Dutch and the Belgium branch has led to a duplication of activities making some positions redundant.

The headcount reductions are higher than expected by the trade unions. The procedure of collective redundancy ('Renault' procedure) has already been launched. On 22 February, the French group will hold an extraordinary European works council. It is the second large internal restructuring after the 'Renault' procedure launched in 2010.


Sources

  • 1 February 2011: L'Echo

Citation

Eurofound (2011), Sanofi Belgium, Internal restructuring in Belgium, factsheet number 71557, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/71557.